Latest Media Releases (Page 4) | Finance News Network

Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Arovella's OroMist R&D facility closure completed (ASX:ALA)

Highlights: Perth-based R&D facility closure has been completed Closure reduces expenditure by approximately $1.5m per annum Part of Arovella’s continued focus on its...read more

CARETEQ - Q3-FY23 ACTIVITIES REPORT & APPENDIX 4C (ASX:CTQ)

Number of new Sofihub contracts won jumps 55% over previous quarter to 34 with a further 18 paid trials currently running Eight of the 34 contracts won and 11 of the 18 tr...read more

Arovella Therapeutics - Response to ASX Query (ASX:ALA)

For more information, download the attached PDF.

Arovella Therapeutics - Quarterly Appendix 4C and Activities Report (ASX:ALA)

MELBOURNE, AUSTRALIA 24 April 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treatme...read more

CARETEQ - ShareCafe Webinar Presentation (ASX:CTQ)

To view the presentation, please download the attached PDF.

Arovella Therapeutics - Response to ASX Aware Query (ASX:ALA)

Dear Sean Response to Aware Query Arovella Therapeutics Limited (ASX:ALA) (“Arovella” or “the Company”) refers to your Aware Query dated 17 April 2023 (“Aware Que...read more

Arovella Therapeutics - ALA-101 confers survival benefit in leukemia model (ASX:ALA)

-- Arovella has presented new data at the American Association for Cancer Research (AACR) Annual Meeting for CAR19-iNKT cells produced using a new 3rd-generation lentiviral vector as planned for cli...read more

Arovella Therapeutics - Response to ASX Price Query (ASX:ALA)

Response to Price Query Arovella Therapeutics Limited (ASX:ALA) (“Arovella” or “the Company”) refers to your Price Query dated 14 April 2023 and provides the followin...read more

Careteq forms Strategic JV (ASX:CTQ)

Highlights: Careteq to merge its Ward MM business with Mederev in a JV to be called Embedded Health Solutions and create one of Australia’s largest aged care medication manageme...read more

Arovella Therapeutics - Appendix 4D and Half Year Report (ASX:ALA)

To view the Appendix 4D and Half Year Report, download the attached PDF.

Careteq - Appendix 4D & Half Year Results (ASX:CTQ)

Highlights: -- Interim revenue increased by 36% to $2.6m as net loss improved materially by ~$1.5m -- Contract wins in US and Australia, expanded suite of offerings, lower costs and contribution...read more

Careteq - Half Year Results Presentation (ASX:CTQ)

To view the presentation, download the attached PDF.

Arovella Therapeutics - Quarterly Appendix 4C and Activities Report (ASX:ALA)

MELBOURNE, AUSTRALIA 31 January 2023: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer treat...read more

Careteq - Q2-FY23 APPENDIX 4C (ASX:CTQ)

To view the Appendix 4C, download the attached PDF.

Careteq - Q2-FY23 ACTIVITIES REPORT (ASX:CTQ)

ACTIVITIES REPORT AND APPENDIX 4C: SIGNIFICANT SALES CONVERSION & SALES PIPELINE EXPANSION Significant increase in contracts won and expansion of sales pipeline for both Sofihub&n...read more

Viewing: 46 - 60 of 200 Previous | Next